<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Extraction extraction-result-8101 - Theorizer</title>
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.15.1/css/all.min.css">
    <link rel="stylesheet" href="../style.css">
</head>
<body>
    <div class="header">
        <a href="../index.html"><i class="fas fa-flask"></i> Theorizer</a>
    </div>

    <div class="content">
        <h1>Extracted Data Details for extraction-result-8101</h1>

        <div class="section">
            <h2>Extracted Data (Header)</h2>
            <div class="info-section">
                <p><strong>Extraction ID:</strong> extraction-result-8101</p>
                <p><strong>Extraction Schema Used (ID):</strong> <a href="../schemas/extraction-schema-147.html">extraction-schema-147</a></p>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of proposed causal mechanisms for Alzheimer's disease, associated risk factors, supporting and contradictory evidence, and methods for detecting the disease, including biomarkers, imaging techniques, cognitive and digital assessments, together with reported diagnostic performance and study details.</div>
                <p><strong>Paper ID:</strong> paper-d523cd8b81546891c1f11a8d2dc7a3ae34ee8b58</p>
                <p><strong>Paper Title:</strong> <a href="https://www.semanticscholar.org/paper/d523cd8b81546891c1f11a8d2dc7a3ae34ee8b58" target="_blank">The PrecivityAD™ Test: Accurate and Reliable LC-MS/MS Assays for Quantifying Plasma Amyloid Beta 40 and 42 and Apolipoprotein E Proteotype for the Assessment of Brain Amyloidosis.</a></p>
                <p><strong>Paper Venue:</strong> Clinica chimica acta; international journal of clinical chemistry</p>
                <p><strong>Paper TL;DR:</strong> The PrecivityAD™ assays are precise, accurate, sensitive, and linear over a wide analytical range, free from significant interferences, and suitable for use in the clinical laboratory.</p>
                <p><strong>Cost:</strong> 0.004</p>
            </div>
        </div>

        <div class="section">
            <h2>Extracted Data (Details)</h2>
            <div class="extraction-instance-container" id="e8101.0">
                <h3 class="extraction-instance">Extracted Data Instance 0 (e8101.0)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of proposed causal mechanisms for Alzheimer's disease, associated risk factors, supporting and contradictory evidence, and methods for detecting the disease, including biomarkers, imaging techniques, cognitive and digital assessments, together with reported diagnostic performance and study details.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>PrecivityAD</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>The PrecivityAD test</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>A clinical LC-MS/MS based assay platform for quantifying plasma amyloid beta 40 (Aβ40) and amyloid beta 42 (Aβ42) and determining apolipoprotein E (ApoE) proteotype, intended to assess brain amyloidosis non-invasively.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>The PrecivityAD™ test: Accurate and reliable LC-MS/MS assays for quantifying plasma amyloid beta 40 and 42 and apolipoprotein E proteotype for the assessment of brain amyloidosis</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>use</td>
                        </tr>
                        <tr>
                            <td><strong>hypothesis_name</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>hypothesis_description</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>supporting_evidence</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>contradictory_evidence</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>risk_factor</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>risk_factor_category</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>detection_method</strong></td>
                            <td>LC-MS/MS quantification of plasma Aβ42 and Aβ40 and apolipoprotein E (ApoE) proteotype (PrecivityAD)</td>
                        </tr>
                        <tr>
                            <td><strong>detection_method_type</strong></td>
                            <td>fluid biomarker</td>
                        </tr>
                        <tr>
                            <td><strong>diagnostic_performance</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>study_design</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>sample_size</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>population_characteristics</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>citation</strong></td>
                            <td>The PrecivityAD™ test: Accurate and reliable LC-MS/MS assays for quantifying plasma amyloid beta 40 and 42 and apolipoprotein E proteotype for the assessment of brain amyloidosis</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'The PrecivityAD™ Test: Accurate and Reliable LC-MS/MS Assays for Quantifying Plasma Amyloid Beta 40 and 42 and Apolipoprotein E Proteotype for the Assessment of Brain Amyloidosis.', 'publication_date_yy_mm': '2021-05'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
        </div>

        <div class="section">
            <h2>Potentially Relevant New Papers (mentioned by this paper)</h2>
            <p class="empty-note">No potentially relevant new papers extracted.</p>
        </div>

        <div class="section">
            <h2>Extracted Data (Debug)</h2>
            <pre><code>{
    "id": "extraction-result-8101",
    "paper_id": "paper-d523cd8b81546891c1f11a8d2dc7a3ae34ee8b58",
    "extraction_schema_id": "extraction-schema-147",
    "extracted_data": [
        {
            "name_short": "PrecivityAD",
            "name_full": "The PrecivityAD test",
            "brief_description": "A clinical LC-MS/MS based assay platform for quantifying plasma amyloid beta 40 (Aβ40) and amyloid beta 42 (Aβ42) and determining apolipoprotein E (ApoE) proteotype, intended to assess brain amyloidosis non-invasively.",
            "citation_title": "The PrecivityAD™ test: Accurate and reliable LC-MS/MS assays for quantifying plasma amyloid beta 40 and 42 and apolipoprotein E proteotype for the assessment of brain amyloidosis",
            "mention_or_use": "use",
            "hypothesis_name": null,
            "hypothesis_description": null,
            "supporting_evidence": null,
            "contradictory_evidence": null,
            "risk_factor": null,
            "risk_factor_category": null,
            "detection_method": "LC-MS/MS quantification of plasma Aβ42 and Aβ40 and apolipoprotein E (ApoE) proteotype (PrecivityAD)",
            "detection_method_type": "fluid biomarker",
            "diagnostic_performance": null,
            "study_design": null,
            "sample_size": null,
            "population_characteristics": null,
            "citation": "The PrecivityAD™ test: Accurate and reliable LC-MS/MS assays for quantifying plasma amyloid beta 40 and 42 and apolipoprotein E proteotype for the assessment of brain amyloidosis",
            "uuid": "e8101.0",
            "source_info": {
                "paper_title": "The PrecivityAD™ Test: Accurate and Reliable LC-MS/MS Assays for Quantifying Plasma Amyloid Beta 40 and 42 and Apolipoprotein E Proteotype for the Assessment of Brain Amyloidosis.",
                "publication_date_yy_mm": "2021-05"
            }
        }
    ],
    "potentially_relevant_new_papers": [],
    "cost": 0.00414825,
    "model_str": "gpt-5-mini"
}</code></pre>
        </div>
        <div class="section">
            <h2>Paper</h2>
            <div class="paper-content"><!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "https://www.w3.org/TR/html4/loose.dtd">
<html>
<head>
<meta charset="utf-8">
<META http-equiv=Content-Type content="text/html">
<meta HTTP-EQUIV="REFRESH" content="2; url='/retrieve/articleSelectSinglePerm?Redirect=https%3A%2F%2Fwww.sciencedirect.com%2Fscience%2Farticle%2Fpii%2FS0009898121001601%3Fvia%253Dihub&amp;key=fbb9ed19d455e5d52332b10914f455b5faf6f199'"/>
<meta name="tdm-reservation" content="1" />
<meta name="tdm-policy" content="https://www.elsevier.com/tdm/tdmrep-policy.json" />
<script type="text/JavaScript" src="/retrieve/static/script/siteCatalystHelper.js"></script>
<script src="https://assets.adobedtm.com/4a848ae9611a/519188bfaff2/launch-d9c9ae460653.min.js"></script>
<title>Redirecting</title>
<META http-equiv=Content-Type content="text/html; charset=utf-8">
<script language=JavaScript type="text/javascript">
var timerStart = Date.now();
var pageName = "";

if (pageName == "") {
    pageName = "Auto Article Locator";
} 
    function autoRedirectToURL() {
        var url = '/retrieve/'+document.getElementById('resultName').value+'?Redirect='+document.getElementById('redirectURL').value+'&key='+document.getElementById('key').value
      window.location = url;
    }

</script>
</head>
<body onload="autoRedirectToURL();">
    <tr style="display:none;">
  <td colspan="2">
<input type="hidden" name="redirectURL" value="https%3A%2F%2Fwww.sciencedirect.com%2Fscience%2Farticle%2Fpii%2FS0009898121001601%3Fvia%253Dihub" id="redirectURL"/>  </td>
</tr>

    <tr style="display:none;">
  <td colspan="2">
<input type="hidden" name="key" value="fbb9ed19d455e5d52332b10914f455b5faf6f199" id="key"/>  </td>
</tr>

    <tr style="display:none;">
  <td colspan="2">
<input type="hidden" name="id" value="S0009898121001601" id="id"/>  </td>
</tr>

    <tr style="display:none;">
  <td colspan="2">
<input type="hidden" name="resultName" value="articleSelectSinglePerm" id="resultName"/>  </td>
</tr>

</body>
<script>

        siteCatalyst.pageDataLoad({
                 businessUnit : 'ELS:RP:ST',
                 environment : 'prod',
                 language : 'en',
                 loadTime : (Date.now() - timerStart).toString(),
                 loadTimestamp : Date.now().toString(),
                 name : pageName,
                 productName : 'IH',
                 type : 'ih:article',        
                 detail : 'sciencedirect',
                 format :"MIME-XHTML",
                 accessType : 'ih:anon_guest',
                 ipAddress : '20.251.202.109',
                 identifierType : 'PII',
                 identifierValue : 'S0009898121001601',
                 articleName : 'The PrecivityAD&trade; test: Accurate and reliable LC-MS\/MS assays for quantifying plasma amyloid beta 40 and 42 and apolipoprotein E proteotype for the assessment of brain amyloidosis',
                 location : "Linking Hub"
        });
    </script>
</html>            </div>
        </div>

    </div>
</body>
</html>